FINDING THE RELATIONSHIP BETWEEN OPHTHALMOPATHY DISEASE WITH SOME CLINICAL, SUBCLINICAL, AND TRAb CONCENTRATIONS IN GRAVES DESEASE

Phạm Thị Ngọc Anh1,, Hoàng Trung Vinh2, Phạm Trọng Văn3
1 Thai Nguyen University of Medicine and Pharmacy
2 Vietnam Military Medical University
3 Hanoi Medical University

Main Article Content

Abstract

Objectives: To find out the relationship between ophthalmopathywith some clinical, subclinical features, TRAb concentration in Graves desease. Subjects and methods: It including 82 patients with Graves' ophthalmopathy. They were admited at the National Hospital of Endocrinology.Research method was used a descriptive cross-sectional study. Results: Male were 3.72 times more likely to develop moderate to life-threatening ophthalmopathy disease than female. There was a relationship between TRAb and FT4 concentrations with the clinical activity of Graves' ophthalmopathywith OR 1.13 and 1.03, respectively, p < 0.01 and p < 0.05. Increased TRAb concentration was associated with exophthalmoson orbital computer tomography with OR 1.07, 95% CI from 1.02 to 1.13, p < 0.05. Conclusion: Men have a higher risk ofsevere ophthalmopathy disease than women. There was a relationship between TRAb concentration and Graves' ophthalmopathy.

Article Details

References

1. Perros, P., Crombie, A. L., Matthews, J. N., và Kendall-Taylor, P. (1993), "Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic", Clin Endocrinol (Oxf). 38(4), pp. 367-72.
2. Li, Q., Ye, H., Ding, Y., Chen, G., và cộng sự. (2017), "Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases", PLoS One. 12(5), p. e0176064.
3. Wiersinga, W. M. và Bartalena, L. (2002), "Epidemiology and prevention of Graves' ophthalmopathy", Thyroid. 12(10), pp. 855-60.
4. Lim, S. L., Lim, A. K., Mumtaz, M., Hussein, E., và cộng sự. (2008), "Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease", Thyroid. 18(12), pp. 1297-301.
5. Nicolì, F., Lanzolla, G., Mantuano, M., Ionni, I., và cộng sự. (2021), "Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy", J Endocrinol Invest. 44(3), pp. 581-585.
6. Gerding, M. N., van der Meer, J. W., Broenink, M., Bakker, O., và cộng sự. (2000), "Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy", Clin Endocrinol (Oxf). 52(3), pp. 267-71.
7. Noh, J. Y., Hamada, N., Inoue, Y., Abe, Y., và cộng sự. (2000), "Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease", Thyroid. 10(9), pp. 809-13.
8. Eckstein, A. K., Plicht, M., Lax, H., Neuhäuser, M., và cộng sự. (2006), "Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease", J Clin Endocrinol Metab. 91(9), pp. 3464-70.